Term ends Mar 7, 2036 · High confidence
20-year base term ends Mar 7, 2036
Mar 7, 2016
Mar 7, 2036
Dec 22, 2020
This patent's term is its 20-year base term, with no adjustment for prosecution delay. A terminal disclaimer is resolved from the filed document, and it ends no earlier than this term, so it shortens nothing. 1 of 3 maintenance fees is paid so far. Confidence: High. from the record
How we calculated this date
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Mar 7, 2016, when application 15/063,461, the earliest non-provisional in its chain, was filed (this one was filed Jun 12, 2020) | Mar 7, 2036 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | None on file | no change | High confidence |
| Terminal disclaimer cap | Disclaimer resolved from the filed document (refs US 10,000,523, US 10,005,811, US 10,239,911, US 10,519,186, US 10,815,266, US 10,870,673, US 10,875,885, US 10,906,928, US 9,828,410) | resolves to Mar 7, 2036, no earlier than this term, so no change | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 1 of 3 maintenance fees paid | In force | High confidence |
| Computed term end | The steps above, in order | Mar 7, 2036 | High confidence |
This family
| US 9,828,410 | In force Mar 2036 | Mar 2036 |
| US 10,005,811 | In force Mar 2036 | Mar 2036 |
| US 10,000,523 | In force Mar 2036 | Mar 2036 |
| US 10,239,911 | In force Mar 2036 | Mar 2036 |
| US 10,815,266 | In force Mar 2036 | Mar 2036 |
| US 10,870,672 | this patent Mar 2036 | Mar 2036 |
| US 10,870,673 | In force Mar 2036 | Mar 2036 |
| US 10,875,885 | In force Mar 2036 | Mar 2036 |
Assignments
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Jun 24, 2020 Reel 53030, frame 202 | Sommadossi, Jean-pierre; Moussa, Adel | Atea Pharmaceuticals, Inc. | Assignment of Assignor's Interest |
| Nov 6, 2026 Reel 76664, frame 870 | Atea Pharmaceuticals, Inc. | Hercules Capital, Inc., as Agent | Security Interest |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
What's changing
A terminal disclaimer resolved from the filed document, referencing US 10,000,523, US 10,005,811, US 10,239,911, US 10,519,186, US 10,815,266, US 10,870,673, US 10,875,885, US 10,906,928, US 9,828,410, ends no earlier than this term, so it caps nothing.